Remission From Depression Is Possible

Similar documents
NOW I M A NEUROSTAR. Let Your Best Self Shine

Transcranial Magnetic Stimulation (TMS)

Bringing. to patients with depression

FDA CLEARS NEUROSTAR TMS THERAPY FOR THE TREATMENT OF DEPRESSION

Patient Education Brief. NeuroStar TMS Therapies

a proven non-drug treatment for depression Get back to well without medication side effects right in your doctor s office.

Frequently Asked Questions FAQS. NeuroStar TMS Therapies

A Patient s Guide: Pursuing Health Care. Reimbursement. for NeuroStar TMS Therapy

Neuromodulation Approaches to Treatment Resistant Depression

Treatment of Depression: A Brief History

Patient Manual Brainsway Deep Transcranial Magnetic Stimulation (Deep TMS) System for Treatment of Major Depressive Disorder

DEEP TMS TREATMENT CONSENT FORM

Transcranial Magnetic Stimulation for the Treatment of Depression

Are you not responding to antidepressants?

Repetitive transcranial magnetic stimulation for depression

Transcranial Magnetic Stimulation: Scientific Underpinnings and Practical Applications

rtms Versus ECT The Future of Neuromodulation & Brain Stimulation Therapies

This initial discovery led to the creation of two classes of first generation antidepressants:

Transcranial Magnetic Stimulation

BRAIN STIMULATION AN ALTERNATIVE TO DRUG THERAPY IN MATERNAL DEPRESSION?

Brain Stimulation. Berry S. Anderson, PhD, RN Mary Rosedale, PhD, PMHNP-BC, NEA-BC Theresa Kormos, PMHCNS-BC Cindy Brown, BSN, RN

ANTI-DEPRESSANT MEDICATIONS

LEASE DO NOT COPY. Setting up atms Clinic

Todd Hutton, M.D. Karl Lanocha, M.D Richard Bermudes, M.D. Kimberly Cress, M.D.

Bright Nights: Understanding Depression

Setting up atms Clinic. Daniel Press, M.D. Assistant Professor in Neurology, Harvard Medical School and Beth Israel Deaconess Medical Center

Diagnosis & Management of Major Depression: A Review of What s Old and New. Cerrone Cohen, MD

Setting up a TMS Treatment Program

The Clinical Application of Transcranial Magnetic Stimulation

FOLLOW DIRECTIONS. How to Use Methadone Safely. U.S. Department of Health & Human Services

Statement on Repetitive Transcranial Magnetic Stimulation for Depression. Position statement CERT03/17

Study No.: Title: Rationale: Phase: Study Period: Study Design: Centers: Indication: Treatment: Objectives: Primary Outcome/Efficacy Variable:

NHS Greater Glasgow And Clyde Pain Management Service. Information for Adult Patients who are Prescribed. Pregabalin. For the Treatment of Pain

Therapeutic Neuromodulation: Overview of a Novel Treatment Platform

Venlafaxine hydrochloride extended-release and other antidepressant medicines may cause serious side effects, including:

Amitriptyline, Nortriptyline or Imipramine

Presentation is Being Recorded

Aripiprazole Accord 5, 10, 15 and 30 mg film-coated tablets

9/20/2011. Integrated Care for Depression & Anxiety: Psychotropic Medication Management for PCPs. Presentation is Being Recorded

Behavioral Modification and Lorcaserin Second Study for Obesity Management

YOUR GUIDE TO ARIPIPRAZOLE Patient/Caregiver Information Brochure

Patient/Caregiver Information Brochure For Bipolar I Disorder in Adolescents

BRAINSWAY DEEP TMS SYSTEM

Michelle Zetoony, DO, FCCP, FACOI th Avenue S, Suite A Phone: Fax:

Medical History. Instructions. My telephone number is: 1 Tools Medical History

Depression. Content. Depression is common. Depression Facts. Depression kills. Depression attacks young people

Therapeutic Uses of Noninvasive Brain Stimulation Current & Developing

Children s Hospital Of Wisconsin

Informed Consent for Weight Management Treatment & Appetite Suppressants Voluntary Enrollment

MIND-CONTROLLED DRONES VIRTUAL REALITY WEIRD INVENTIONS KITCHEN CHEMISTRY

Transcranial Direct Current Stimulation (tdcs) A Promising Treatment for Depression?

The Next Chapter in Brain Stimulation Therapy

Frequently Asked Questions

Study No.: Title: Rationale: Phase: Study Period: Study Design: Centers Indication: Treatment: Objectives: Primary Outcome/Efficacy Variable:

POLICY TITLE: Transcranial Magnetic Stimulation (TMS)

Disability Risk Management in Today s Workforce: Chronic Pain and Opioid Addiction

Lemilvo Tablets (aripiprazole)

MEDICATION GUIDE Savella (Sa-vel-la) (milnacipran HCl) Tablets

MagPro by MagVenture. Versatility in Magnetic Stimulation

NEURONETICS. 510(k) SUMMARY NEUROSTAR TMS THERAPY SYSTEM'

HealthTalks. Deep Brain Stimulation for Parkinson s Disease Patients

Dementia Medications Acetylcholinesterase Inhibitors (AChEIs) and Glutamate (NMDA) Receptor Antagonist

Silver Child Development Center New Patient Questionnaire. Relation (circle) Biological Mother Stepmother Adoptive Mother

Wellbutrin/Wellbutrin-SR/ Wellbutrin-XL (bupropion)

Working within the core competencies of paraprofessionals

About Your Pain Management

Amarillo Surgical Group Doctor: Date:

ISSUES WITH THE PRESENT FDA ON THE MATTER OF 510(k) CLEARANCE

MagPro by MagVenture. Versatility in Magnetic Stimulation

About Your Pain Management

PHENTERMINE INFORMATION SHEET

PATIENT REGISTRATION

NCI Community Oncology Research Program Kansas City (NCORP-KC)

New Patient Pain Evaluation

Patient Name: Date: Address: Primary Care Physician: Online Website On TV In print On the radio

Zinging the Blues. By Kathy Svitil

Depression & Anxiety in Adolescents

Case 2:15-cv MWF-JPR Document Filed 03/20/17 Page 1 of 36 Page ID #:388 EXHIBIT 1

Abilify (aripiprazole)

FAQ - ARIPIPRAZOLE Educational materials for the Healthcare profesionals

Norpramin (desipramine)

SUBOXONE (buprenorphine and naloxone) sublingual film (CIII) IMPORTANT SAFETY INFORMATION

KEY MESSAGES. It is often under-recognised and 30-50% of MDD cases in primary care and medical settings are not detected.

Some newer, investigational approaches to treating refractory major depression are being used.

Patient s guide for switching to

Guidelines MANAGEMENT OF MAJOR DEPRESSIVE DISORDER (MDD)

Appendix 4B - Guidance for the use of Pharmacological Agents for the Treatment of Depression in Adults (18 years and over)

The legally binding text is the original French version TRANSPARENCY COMMITTEE. Opinion. 1 October 2008

2018 Otsuka Pharmaceutical Development & Commercialization, Inc., Rockville, MD Lundbeck, LLC.

(emergency room pain)

MEDICATION GUIDE. Aripiprazole Tablets (AR-i-PIP-ra-zole)

Oscar G. Morales. MD Founding Director McLean Hospital TMS

Original Effective Date: 8/28/2013. Subject: Transcranial Magnetic Stimulation for the Treatment of Major Depression

Presenter. Dr. Ronald Lucchino

APPROPRIATE USE GUIDE

Corinna Mosher, M.D. A Medical Corporation 415 E. Rolling Oaks Drive Suite #280 Thousand Oaks, CA (805) Fax (805)

Transcription:

Remission From Depression Is Possible

About Depression Over 350 million people worldwide suffer from depression 1 While medications may help manage symptoms of depression, many patients are not satisfied with the results from standard drug therapy due to: Lack of efficacy or Intolerable side effects Major depression is a serious medical illness.

About Depression Causes of depression While the exact cause of depression is not known, the leading scientific theory is that it is caused by an imbalance of the brain s neurotransmitters, which are chemical messengers that send signals between brain cells. Normal Depressed Source: Mark George, M. D. Biological Psychiatry Branch Division of Intramural Research Programs, NIMH 1993

About Depression What impact does depression have on your life? Relationships Work Finances Quality of life What was your life like before your depression?

About Depression Treating depression While antidepressant drugs work for many people, some still do not receive adequate treatment. 1 For these patients, the effects of depression can still be debilitating Patients are looking for alternatives

Proven non-drug treatment for depression NeuroStar TMS Therapy for depression is: FDA-cleared for patients who have not benefited from prior antidepressant medication Free from side effects often associated with medications NeuroStar Proven Safe and Effective

Remission from depression is possible Many patients depression symptoms significantly improved or went away after 4 to 6 weeks of treatment with NeuroStar. 1 in 2 patients experienced significant improvement 1 in 3 patients were symptom free In an NIMH-funded, independent, randomized controlled trial, patients treated with TMS using the NeuroStar TMS System were four times more likely to achieve remission compared to patients receiving sham treatment (P = 0.0173; odds ratio = 4.05). 2 NeuroStar Proven Safe and Effective

Top psychiatry hospitals provide NeuroStar Johns Hopkins Hospital McLean Hospital Sheppard and Enoch Pratt Hospital Mayo Clinic UCLA Other notable hospitals and institutions include: Stanford Hospital Alegent Health Berenson-Allen Center for Noninvasive Brain Stimulation (Beth Israel DMC) Florida Hospital University of Michigan Butler Hospital/Brown University Medical University of South Carolina Rush University Walter Reed University of Florida Loma Linda University Boston University University of South Florida Southern Illinois University NeuroStar Proven Safe and Effective

Safe and easy to tolerate Free from the side effects often associated with antidepressant medication 3,5 NeuroStar: Other Adverse Events 5 Eye Pain Pain of Skin Toothache Facial Pain Muscle Twitching Adverse events for Neurostar are transient, occur during TMS treatment and do not occur for most patients after the first week of treatment. 3 ANTIDEPRESSANT MEDICATIONS: Other Adverse Events 5 Nervousness Constipation Anxiety Drowsiness Tremor Sweating Decreased Appetite Impotence Headache/Migraine Increased Appetite Diarrhea Abnormal Ejaculation Decreased Sexual Interest Treatment Discontinuation Side Effects From product labeling for currently marketed antidepressant medications. Fatigue Weight Gain GI Distress Sexual Dysfunction Nausea Insomnia Blurred Vision Dry Mouth Antidepressant Medications Most Common Side Effects Pain or Discomfort NeuroStar TMS Therapy Adverse events occurring at an incidence >5% and 2x the rate of placebo treatment. 5 NeuroStar Proven Safe and Effective

NeuroStar TMS Therapy Patients are awake and alert during treatment In-office treatment takes 37 minutes Patients receive therapy 5 days a week, for 4 to 6 weeks Patients can go back to their normal activities immediately after treatment NeuroStar TMS Therapy

A targeted approach Transcranial Magnetic Stimulation (TMS) Uses a targeted pulsed magnetic field, similar to what is used in an MRI (magnetic resonance imaging) machine NeuroStar TMS Therapy stimulates areas of the brain that are underactive in depression 4 LEFT PREFRONTAL CORTEX ANTERIOR CINGULATE STRIATUM HYPOTHALAMUS AMYGDALA HIPPOCAMPUS NeuroStar TMS Therapy

Simple steps for NeuroStar treatment Step One: The patient reclines comfortably in the treatment chair, awake and alert Step Two: A small curved device containing the magnetic coil rests lightly on the patient s head Step Three: The device delivers focused magnetic stimulation directly to the target areas of the brain Step Four: The patient can immediately resume normal activities NeuroStar TMS Therapy

Getting started Physician prescribes NeuroStar TMS Therapy Review your insurance and payment options Schedule first treatment NeuroStar TMS Therapy

About NeuroStar TMS Therapy NeuroStar TMS Therapy is indicated for the treatment of Major Depressive Disorder in adult patients who have failed to receive satisfactory improvement from prior antidepressant medication in the current episode. NeuroStar TMS Therapy is only available by prescription. For complete prescribing information please visit NeuroStar.com. The most common side effect is pain or discomfort at or near the treatment site. These events are transient; they occur during the TMS treatment course and do not occur for most patients after the first week of treatment. There is a rare risk of seizure associated with the use of NeuroStar TMS (<0.1% per patient). References 1. World Health Organization. Depression fact sheet No.369. http://www.who.int/mediacentre/factsheets/fs369/en/index.html Accessed May 21, 2014. 2. Carpenter LL, et al. (2012). Depress Anxiety, 29(7):587-596. 3. Janicak PG, et al. (2008). J Clin Psychiatry, 69(2):222-232. 4. George MS, et al. (2010). Arch Gen Psychiatry, 67(5):507-516. 5. Important Safety Information

To hear how real NeuroStar patients have benefited: 2014 Neuronetics, Inc., Malvern, PA 53-50234-000 Rev C 05/14 Remission from Depression is Possible www.neurostar.com